Arsenic trioxide and all- trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial by Burnett, Alan K, Prof, Russell, Nigel H, Prof, Hills, Robert K, DPhil, Bowen, David, Prof, Kell, Jonathan, MD, Knapper, Steve, DM, Morgan, Yvonne G, PhD, Lok, Jennie, MSc, Grech, Angela, BA, Jones, Gail, MD, Khwaja, Asim, Prof, Friis, Lone, PhD, McMullin, Mary Frances, Prof, Hunter, Ann, MD, Clark, Richard E, Prof, Grimwade, David, Prof

Get full text